AstraZeneca
The Labelling Strategy Director provides regulatory labelling expertise and guidance for complex drug projects across therapy and disease areas, supporting global regulatory submission/execution and product labelling teams. The role shapes and implements labelling strategy and maintains core product information for marketed and pipeline products while contributing to team development and resource planning.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
Labelling Strategy Director
American Association of Physicists in Medicine
Senior Manager, Core Labelling Strategy (12 month agency contract)
Viatris
Director Core Labeling Strategy
Viatris
Executive Director - Strategic Labelling
GSK plc
Director, Global Labeling Strategy, Team Leader
Bristol Myers Squibb
Director, Global Regulatory Labeling Strategy
Takeda Pharmaceutical Company Limited